Clinicopathological and molecular differences between stage IV screen-detected and interval colorectal cancers in the Flemish screening program
We identified NETs and lymphovascular invasion as factors associated with increased odds of having a stage IV FIT-IC. Moreover, we highlight the importance of tumor location as a covariate in evaluating FIT-IC related factors. More research across all stages is needed to clarify how these insights might help to optimize the Flemish CRC screening program.
Authors
- Guy Van Camp (ORCID: https://orcid.org/0000-0001-5105-9000)
- Guido F. Van Hal (ORCID: https://orcid.org/0000-0002-4611-4076)
- Koen Van Herck (ORCID: https://orcid.org/0000-0003-0717-2406)
- Marc Peeters (ORCID: https://orcid.org/0000-0003-4969-2303)
- Sharon Janssens (ORCID: https://orcid.org/0000-0001-9472-5341)
- Erik Fransén (ORCID: https://orcid.org/0000-0001-7785-4790)
- Ken Op de Beeck (ORCID: https://orcid.org/0000-0001-5527-6838)
- Allegra Ferrari (ORCID: https://orcid.org/0000-0003-3055-2132)
- Isabelle Neefs (ORCID: https://orcid.org/0000-0001-8500-389X)
- Thuy Ngan Tran (ORCID: https://orcid.org/0000-0002-6799-6477)
- Sarah Hoeck (ORCID: https://orcid.org/0000-0001-8754-3953)
Institutions
- University of Antwerp (BE)
- Antwerp University Hospital (BE)
- University of Genoa (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-02
- DOI
- https://doi.org/10.3389/fonc.2024.1409196
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds Wetenschappelijk Onderzoek
- Universiteit Antwerpen
- Vlaamse regering